Order results by:
Issue | Title | |
Vol 14, No 2 (2021) | Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis | Abstract similar documents |
A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova | ||
"... Objective: to perform cost-effectiveness analysis of the treatment for adult patients ..." | ||
Vol 15, No 1 (2022) | Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution | Abstract similar documents |
O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov | ||
"... Objective: pharmacoepidemiological analysis of medication list used in a multidepartmental ..." | ||
Vol 14, No 3 (2021) | Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital | Abstract similar documents |
L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva | ||
"... expenditure was carried out using ABC/VEN analysis. Results. The total expenditure on the procurement ..." | ||
Vol 16, No 4 (2023) | Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development | Abstract PDF (Eng) similar documents |
V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan | ||
"... . The analysis of scientific publications in the field of marketing research of drugs, found in eLibrary ..." | ||
Vol 12, No 3 (2019) | Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings | Abstract similar documents |
O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev | ||
"... Aim: to conduct a pharmacoepidemiological analysis of antimicrobial therapy of burn injury ..." | ||
Vol 16, No 2 (2023) | Pharmacoepidemiological and drug interaction analysis in the treatment of chronic renal and hepatic failure | Abstract similar documents |
O. V. Zhukova, D. S. Fokina, O. V. Ruina, M. V. Khazov | ||
"... Objective: to perform pharmacoepidemiological and drug interaction analysis of pharmacotherapy ..." | ||
Vol 11, No 4 (2018) | Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis | Abstract similar documents |
I. A. Narkevich, O. D. Nemyatyh, D. D. Siukaeva, I. V. Pavlushkov, D. O. Ivanov, Ya. V. Panyutina | ||
"... The aim of the study is to determine the limits of using the mathematical-statistical analysis ..." | ||
Vol 14, No 2 (2021) | Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation | Abstract similar documents |
D. G. Shchurov, V. S. Dombrovskiy | ||
"... , including the dependency on the status of blood coagulation, as well as cost data. The analysis was carried ..." | ||
Vol 12, No 2 (2019) | Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria | Abstract similar documents |
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova | ||
"... . The economic assessment was made using the cost-effectiveness analysis and budget impact analysis. The cost ..." | ||
Vol 15, No 1 (2022) | Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation | Abstract similar documents |
T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg | ||
"... and methods. Original partitioned survival analysis model was developed to assess the cost-effectiveness ..." | ||
Vol 14, No 3 (2021) | Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer | Abstract similar documents |
O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova | ||
"... on the analysis of its cost and effectiveness in patients with chronic pain syndrome in pancreatic cancer ..." | ||
Vol 16, No 3 (2023) | Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia | Abstract similar documents |
A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva | ||
"... analysis of extracts from 157 medical records of middle-aged patients in accordance with the World Health ..." | ||
Vol 16, No 3 (2023) | Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study | Abstract similar documents |
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina | ||
"... to the equivalence of strategies regarding overall and non-progressive survival, the cost minimization analysis ..." | ||
Vol 16, No 3 (2023) | Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia | Abstract similar documents |
N. A. Avxentyev, Yu. V. Makarova | ||
"... Objective: to perform a cost-effectiveness analysis of using encorafenib and binimetinib ..." | ||
Online First | Chemo-рroteomic analysis of the pharmacological properties of vitamin В12 derivatives | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, I. A. Dereven’kov, L. A. Maiorova | ||
"... . Material and methods. Using the method of chemoinformational (chemoproteomic) analysis, implemented within ..." | ||
Online First | STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia | Abstract similar documents |
A. V. Zhuravlev, O. I. Knysh | ||
"... Objective: to conduct a STEP analysis (social, technological, economic, political) of macro ..." | ||
Vol 16, No 1 (2023) | Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022 | Abstract similar documents |
D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, M. A. Polzikov, A. S. Semikhin | ||
"... Objective: to perform a clinical and economic analysis of using drugs containing follitropin alfa ..." | ||
Vol 13, No 2 (2020) | Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation | Abstract similar documents |
S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova | ||
Vol 15, No 1 (2022) | Pharmacoeconomic analysis of the application of follitropin alfa in combination with assisted reproductive technologies | Abstract similar documents |
K. A. Perova, D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, N. Z. Musina | ||
"... and methods. A cost minimization analysis to evaluate clinical-economic feasibility of follitropin alfa ..." | ||
Vol 12, No 2 (2019) | Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers | Abstract similar documents |
E. V. Radchenko, A. S. Kolbin | ||
Vol 12, No 3 (2019) | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support | Abstract similar documents |
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov | ||
"... Clinical / Economic Analysis and the common ABC / VEN analysis are currently used to estimate ..." | ||
Vol 12, No 4 (2019) | Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis | Abstract similar documents |
I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva | ||
"... Aim: to conduct a comparative clinical and economic analysis of using three SYSADOA drugs ..." | ||
Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation | Abstract similar documents |
S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev | ||
"... Objective – to conduct a pharmacoeconomic analysis of using omalizumab, mepolizumab and reslizumab ..." | ||
Vol 13, No 4 (2020) | Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard | Abstract similar documents |
I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova | ||
"... Aim. A meta-analysis of 8 controlled studies (n=771, age 53.6±6.2 years) of tie use of tie ..." | ||
Vol 15, No 2 (2022) | Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis | Abstract similar documents |
O. S. Mikhaylova, A. V. Krikova | ||
"... Background. The cost-of-illness (COI) analysis allows to estimate and plan costs for calculations ..." | ||
Vol 14, No 1 (2021) | Differences in the standardization of medicinal products based on extracts of chondroitin sulfate | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, B. Ts. Zaychik, E. V. Shikh, A. O. Ruzhitskiy, A. N. Galustyan, I. S. Sardaryan, I. V. Sarvilina | ||
"... Objective: a comparative analysis of 6 different chondroprotectors for injection, containing ..." | ||
Vol 16, No 4 (2023) | Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma | Abstract similar documents |
S. V. Nedogoda, A. S. Salasyuk, S. N. Avdeev, I. N. Barykina, V. O. Lutova, E. A. Popova | ||
"... in the Russian Federation. Material and methods. A clinical and economic analysis of using benralizumab ..." | ||
Vol 16, No 2 (2023) | Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy | Abstract similar documents |
M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina | ||
Vol 16, No 3 (2023) | Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer | Abstract similar documents |
I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova | ||
"... . Pharmacoeconomic cost-effectiveness analysis, sensitivity analysis of the selected model to changes in its initial ..." | ||
Vol 16, No 2 (2023) | Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination | Abstract similar documents |
I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova | ||
"... Objective: to conduct a comparative pharmacoeconomic analysis of using follitropin delta ..." | ||
Vol 12, No 1 (2019) | Prevalence survey of musculoskeletal and connective tissue disorders in the Russian Federation | Abstract similar documents |
T. A. Oleynikova, D. N. Pozhidaeva, A. Yu. Oreshko | ||
"... and connective tissue disorders in the Russian Federation. The analysis covers the entire country as well ..." | ||
Vol 12, No 2 (2019) | Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava | ||
"... of cardiovascular mortality or for any other outcomes mentioned by the authors. A detailed analysis of this text ..." | ||
Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer | Abstract similar documents |
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov | ||
"... consisted of two parts: clinical and economic study and budget impact analysis. We used cost minimization ..." | ||
Vol 15, No 3 (2022) | Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation | Abstract similar documents |
N. A. Avxentyev, Yu. V. Makarova | ||
"... . Objective: to perform a long-term analysis of canagliflozin budget impact in adult patients with DM2 and DN ..." | ||
Vol 15, No 3 (2022) | Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis | Abstract similar documents |
А. V. Kukurika | ||
"... drug-resistant tuberculosis (MDR/XDR-TB) chemotherapy regimens. Material and methods. An analysis ..." | ||
Vol 15, No 2 (2022) | Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings | Abstract similar documents |
M. V. Zhuravleva, S. N. Avdeev, Yu. V. Gagarina, T. V. Marin | ||
"... and budget impact analysis methods were used. The current practice of treating patients with SA ..." | ||
Vol 14, No 2 (2021) | Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, Yu. I. Zhuravlev | ||
"... chemoreactome analysis is based on the topological recognition theory advanced by the Institute ..." | ||
Vol 14, No 2 (2021) | Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA | Abstract similar documents |
E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev | ||
"... in R and Python programming environments). Avenues for further investigation may include analysis ..." | ||
Vol 13, No 2 (2020) | Affordability of in vivo gene therapy. Problems and potential solutions | Abstract similar documents |
V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko | ||
"... pharmaceutical market. The analysis of the methodology used in the found CESs was performed based on the given ..." | ||
Vol 13, No 3 (2020) | Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making | Abstract similar documents |
V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy | ||
"... on multi-criteria analysis of decision making. Materials and methods. The study included 4 main stages ..." | ||
Vol 13, No 3 (2020) | Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov | ||
"... by the method of chemoinformation analysis. Materials and methods. Сomparative chemomicrobiome analysis ..." | ||
Vol 13, No 3 (2020) | Economic burden of systemic sclerosis: systematic review | Abstract similar documents |
D. L. Klabukova, V. S. Krysanova, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin | ||
Vol 13, No 4 (2020) | Pharmacoeconomic feasibility of using the drug Hemangiol (propranolol, oral solution) in the treatment of proliferating infantile hemangioma requiring systemic therapy | Abstract similar documents |
I. N. Dyakov, S. R. Varfolomeеva | ||
"... systemic therapy. Materials and methods. The study design was a retrospective analysis of the published ..." | ||
Vol 15, No 1 (2022) | Pharmacoeconomic analysis of using Monofer in patients with iron deficiency anemia as part of the provision of medical care under the state guarantees program in the health care system of the Russian Federation | Abstract similar documents |
R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, O. A. Gromova, I. Yu. Torshin | ||
"... Objective: comparative pharmacoeconomic analysis of iron preparations for intravenous infusion ..." | ||
Vol 15, No 1 (2022) | Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update | Abstract similar documents |
V. D. Sokolova, N. A. Sableva, V. V. Mladov, D. G. Tolkacheva | ||
"... to be updated. Objective: to update the existing systematic review and network meta-analysis comparing efficacy ..." | ||
Vol 14, No 3 (2021) | An economic evaluation of pre-dialysis stage of chronic kidney disease | Abstract similar documents |
E. I. Rumiantseva, M. V. Avxentyeva | ||
Vol 14, No 4 (2021) | Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
I. Yu. Torshin, A. M. Lila, O. A. Gromova | ||
"... of the theory of topological text analysis, an intellectual analysis of 2319 publications on fundamental ..." | ||
Vol 14, No 4 (2021) | Prospects of using chondroprotectors for the treatment of pulmonary pathology | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin | ||
"... the methods of the theory of text topological analysis an intellectual analysis of 1273 publications ..." | ||
Vol 16, No 2 (2023) | Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients | Abstract similar documents |
E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov | ||
"... patients with moderate and severe CPS and a meta-analysis of randomized controlled trials, no differences ..." | ||
Vol 16, No 2 (2023) | Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic | Abstract similar documents |
Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham | ||
"... patients. Objective: to perform pharmacoeconomic analysis of ART regimens HIV-infected in patients in SAR ..." | ||
1 - 50 of 64 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)